These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6768161)

  • 41. Kinetics of heparin action.
    Shore JD; Olson ST; Craig PA; Choay J; Björk I
    Ann N Y Acad Sci; 1989; 556():75-80. PubMed ID: 2786689
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison of the kinetic behavior of human and bovine proteins in the heparin-catalyzed antithrombin III/thrombin reaction.
    Cunningham MT; Nelsestuen GL
    Biochim Biophys Acta; 1987 Jan; 911(1):66-70. PubMed ID: 3790599
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxidation of human alpha-thrombin by the myeloperoxidase-H2O2-chloride system: structural and functional effects.
    De Cristofaro R; Landolfi R
    Thromb Haemost; 2000 Feb; 83(2):253-61. PubMed ID: 10739383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reaction of antithrombin with proteases. Evidence for a specific reaction with papain.
    Valeri AM; Wilson SM; Feinman RD
    Biochim Biophys Acta; 1980 Aug; 614(2):526-33. PubMed ID: 7407200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of monovalent cations on the heparin-enhanced antithrombin III/thrombin reaction.
    Griffith MJ; Beavers G; Kingdon HS; Lundblad RL
    Thromb Res; 1980 Jan 1-15; 17(1-2):29-39. PubMed ID: 7376137
    [No Abstract]   [Full Text] [Related]  

  • 46. Abolition by dextran sulfate of the heparin-accelerated antithrombin III/thrombin reaction.
    Oshima G; Nagai T; Nagasawa K
    Thromb Res; 1984 Sep; 35(6):601-11. PubMed ID: 6209818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
    Scully MF; Kakkar VV
    Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The antiheparin effect of alpha1-acid glycoprotein probably due to steric hindrance of the heparin-thrombin interaction.
    Andersen P; Godal HC
    Thromb Res; 1979; 15(5-6):857-68. PubMed ID: 494182
    [No Abstract]   [Full Text] [Related]  

  • 49. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
    Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA
    Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.
    Griffith MJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5460-4. PubMed ID: 6577437
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of human thrombomodulin on the inactivation of thrombin by human antithrombin III.
    Hirahara K; Koyama M; Matsuishi T; Kurata M
    Thromb Res; 1990 Jan; 57(1):117-26. PubMed ID: 2154059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of heparin modification on its activity in enhancing the inhibition of thrombin by antithrombin III.
    Danishefsky I; Ahrens M; Klein S
    Biochim Biophys Acta; 1977 Jun; 498(1):215-22. PubMed ID: 560216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leucocyte migration inhibition factor (LIF) and antithrombin III (AT III).
    Weber TH; Mäkinen T; Welin MG
    J Clin Lab Immunol; 1980 Jul; 4(1):47-8. PubMed ID: 7007650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate.
    Sié P; Fernandez F; Caranobe C; Gabaig AM; Boneu B
    Thromb Res; 1984 Jul; 35(2):231-6. PubMed ID: 6206589
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of heparin and low molecular weight heparins on thrombin-induced blood platelet activation in the absence of antithrombin III.
    Baruch D; Franssen J; Hemker HC; Lindhout T
    Thromb Res; 1985 Jun; 38(5):447-58. PubMed ID: 3160132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors.
    Weitz JI; Leslie B; Hudoba M
    Circulation; 1998 Feb; 97(6):544-52. PubMed ID: 9494024
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synergistic inhibition by antithrombin III and heparin-like compounds of thrombin-induced platelet aggregation [proceedings].
    Kindness G; Williamson FB; Long WF
    Biochem Soc Trans; 1980 Feb; 8(1):85-6. PubMed ID: 6154614
    [No Abstract]   [Full Text] [Related]  

  • 58. Respective roles of antithrombin III and alpha 2 macroglobulin in thrombin inactivation.
    Fischer AM; Tapon-Bretaudiere J; Bros A; Josso F
    Thromb Haemost; 1981 Feb; 45(1):51-4. PubMed ID: 6166063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measurement of the heparin enhanced-antithrombin III/thrombin reaction rate in the presence of synthetic substrate.
    Griffith MJ
    Thromb Res; 1982 Feb; 25(3):245-53. PubMed ID: 7064134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthetic selective inhibitors of thrombin.
    Okamoto S; Hijikata-Okunomiya A
    Methods Enzymol; 1993; 222():328-40. PubMed ID: 8412802
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.